Boston City Councilor Visited Dana-Farber to Learn About EQUAL Study
Dana-Farber Cancer Institute shared on LinkedIn:
“Last week, Boston City Councilor At-Large Henry Santana visited to learn more about the EQUAL study, where investigators are studying a new blood test to screen for Epidermal Growth Factor Receptor (EGFR) positive lung cancer in healthy individuals at risk for the disease who cannot undergo regular lung cancer screening.
Principal investigator and thoracic oncologist Narjust Florez, associate director of the Cancer Care Equity Program, designed the study in response to rising rates of lung cancer in younger people and the prevalence in individuals of Asian or Hispanic/Latinx descent who have never used tobacco.
Thank you, Councilor Santana, for taking the time to learn more about advancing equitable lung cancer screening and research.
More information on the study can be found here.”
More posts featuring Dana-Farber Cancer Institute.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023